{
  "paper_metadata": {
    "pmid": "18597679",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper reports a novel de novo BRCA2 splice site mutation and provides detailed penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8754+1 G>A",
      "protein_notation": null,
      "genomic_position": "nucleotide 8982+1",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "40 years old, female, Danish",
        "phenotype": "ductal carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": 40,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ductal carcinoma",
          "evidence_sentence": "The patient was diagnosed with breast cancer at the age of 40."
        }
      ],
      "functional_data": {
        "summary": "The mutation activates a cryptic splice site 46 base pairs 3' of exon 21, resulting in a truncated BRCA2 protein.",
        "assays": [
          "exon trapping in COS-7 cells",
          "RT-PCR on RNA isolated from whole blood"
        ]
      },
      "segregation_data": "The mutation was not found in the patient's parents or sister, indicating it is a de novo mutation.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The mutation is classified as disease-causing and has not been previously reported in the BIC database.",
      "key_quotes": [
        "We conclude that the novel BRCA2 splice variant is a de novo mutation introduced in the male spermatozoa that can be classified as a disease causing mutation.",
        "The mutation leads to the activation of a cryptic splice site 46 base pairs 3' of exon 21 and introduces a premature stop codon and thereby a truncated BRCA2 protein."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}